Current strategy for leprosy control in Brazil: Time to pursue alternative preventive strategies?

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 16, Issue 5, 2004, Pages 362-365

  Cunha, Sérgio S ^a,b   Rodrigues, Laura C ^a   Duppre, Nádia Cristina ^c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Instituto de Saude de Sao Paulo   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Brazil; Leprosy; Prevention and control

Indexed keywords

BCG VACCINE; LEPROSTATIC AGENT;

DISEASE CONTROL; HEALTH CARE; LEPROSY;

BCG VACCINATION; BRAZIL; CHEMOPROPHYLAXIS; COMBINATION CHEMOTHERAPY; DISEASE TRANSMISSION; EARLY DIAGNOSIS; ECONOMICS; HUMAN; LEPROSY; LEPROSY CONTROL; REVIEW;

BRAZIL; SOUTH AMERICA; WESTERN HEMISPHERE; WORLD;

EID: 9244237017     PISSN: 10204989     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1020-49892004001100014     Document Type: Review

References (28)

1. United Nations Development Programme. Human Development Report 2003. Available from: www.undp.org/hdr2003. Accessed 4 July 2003.
2. World Health Organization. Global leprosy situation-Leprosy situation in Americas. 2003. Available from http://www.who.int/lep/stat2002/Americas02.htm. Accessed 30 June 2004
3. Cunha SS, Rodrigues LC, Moreira S, Carvalho LC, Barreto ML, Dourado I. Upward trend in the rate of detection of new cases of leprosy in the State of Bahia, Brazil. Int J Lepr 2001;69:308-17.
4. Figueiredo IA, Silva AAM. Aumento na detecção de casos de hanseniase em São Luiz, Maranhão, Brazil, de 1993 a 1998. A endemia está em expansao? [Increase in leprosy detection rates in São Luiz, Maranhão, Brazil, from 1993 to 1998. Is the endemic expanding?]. Cad Saúde Pública 2003;19:439-45.
5. Kerr-Pontes LR, Montenegro AC, Barreto ML, Werneck GL, Feldmeier H. Inequality and leprosy in Northeast Brazil: an ecological study. Int J Epidemiol 2004;33:262-9.
6. Martelli CM, Moraes Neto OL, Andrade AL, Silva SA, Silva IM, Zicker F Spatial patterns of leprosy in an urban area of central Brazil. Bull World Health Organ 1995;73(3):315-9.
7. WHO. Guidelines for carrying out leprosy elimination campaigns 1996. WHO Action Programme for the Elimination of Leprosy. Lepr Rev 1999;70:408-27.
8. World Health Organization. The Final Push Strategy to Eliminate Leprosy as a Public Health Problem. Questions and Answers. 2002. Available from: http://www.who.int/lep/Elimination/Elimination0.htm. Accessed 22 August 2003.
9. Meima A, Richardus JH, Habbema JD. Trends in leprosy case detection worldwide since 1985. Lepr Rev 2004;75:19-33.
10. Groenen G. Trends in prevalence and case finding in the ALERT leprosy control programme, 1979-1999. Lepr Rev 2002;73:29-40.
11. Lockwood DN. Leprosy eliminationa virtual phenomenon or a reality? Br Med J 2002;22:1516-8.
12. Motta CP, Zuniga M. Time trends of Hansen's disease in Brazil. Int J Lepr Other Mycobact Dis 1990;58(3):453-61.
13. Technical Forum of the International Leprosy Association. Prevention of disabilities and rehabilitation. Lepr Rev 2002;73:S35-43.
14. Brasil, Ministério da Saúde. Hanseniase. Vigilância Epidemiológica de Doenças e Agravos Específicos. In: Vigilância Epidemiológica de Doenças e Agravos Específicos; 2001. Available from: http://www.funasa.gov.br/pub/GVE/GVE05 13A.htm. Accessed 20 July 2003.
15. Fine PE. Primary prevention of leprosy. Int J Lepr Other Mycobact Dis 1996;64 (4 Suppl):S44-9.
16. Lombardi C, Pedrazzani ES, Pedrazzani JC, Filho PF, Zicker F. Protective efficacy of BCG against leprosy in Sao Paulo. Bull Pan Am Health Organ 1996;30(1): 24-30.
17. Convit J, Smith PG, Zuniga M, Sampson C, Ulrich M, Plata JA, et al. BCG vaccination protects against leprosy in Venezuela: a case-control study. Int J Lepr Other Mycobact Dis 1993;61(2):185-91.
18. Rodrigues ML, Silva SA, Neto JC, de Andrade AL, Martelli CM, Zicker F. Protective effect of intradermal BCG against leprosy; a case-control study in central Brazil. Int J Lepr Other Mycobact Dis 1992;60(3):335-9.
19. Matos H, Duppre N, Alvin M, Vieira L, Sarno E, Struchiner C. Epidemiologia da hanseníase em coorte de contatos intradomiciliares no Rio de Janeiro (1987-1991). Cad Saúde Publica 1999;15:533-42.
20. Duppre N, Sales JAC, Pereira AM, Matos H, Sarno EN. BCG revaccination on leprosy contacts: preliminary results. Int J Lepr Other Mycobact Dis 2002;70:166A.
21. Noordeen SK. Prophylaxis - scope and limitations. Int J Lepr Other Mycobact Dis 2001;69:S16-20.
22. Fine PE, Sterne JA, Ponnighaus JM, Bliss L, Saui J, Chihana A, et al. Household and dwelling contact as risk factors for leprosy in northern Malawi. Am J Epidemiol 1997;146(1):91-102.
23. Bakker MI, Hatta M, Kwenang A, Klatser PR, Oskam L. Epidemiology of leprosy on five isolated islands in the Flores Sea, Indonesia. Trop Med Int Health 2002;7:780-7.
24. Gupte MD, Vallishayee RS, Anantharaman DS, Nagaraju B, Sreevatsa, Balasubramanyam S, et al. Comparative leprosy vaccine trial in south India. Indian J Lepr 1998;70(4):369-88.
25. van Beers SM, Hatta M, Klatser PR. Patient contact is the major determinant in incident leprosy: implications for future control. Int J Lepr Other Mycobact Dis 1999;67(2):119-28.
26. Klatser PR. Strategies for pro-active case-finding in leprosy control. Int J Lepr 2001;69:S30-2.
27. Smith CM, Smith WCS. Chemoprophylaxis is effective in the prevention of leprosy in endemic countries: a systematic review and meta-analysis. J Infect 2000;41:137-42.
28. Buhrer-Sekula S, Smits HL, Gussenhoven GC, Van Leeuwen J, Amador S, Fujiwara T, et al. Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J Clin Microbiol 2003;41:1991-5.